Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells

Correction for ‘Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells’ by Lingling Xu et al., RSC Adv., 2022, 12, 18004–18011. https://doi.org/10.1039/D2RA02301F.

Detalles Bibliográficos
Autores principales: Xu, Lingling, Zhou, Chuan, Wang, Fan, Liu, Huiqin, Dong, Guangyuan, Zhang, Siyi, Liu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248366/
https://www.ncbi.nlm.nih.gov/pubmed/35865561
http://dx.doi.org/10.1039/d2ra90065c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248366/
https://www.ncbi.nlm.nih.gov/pubmed/35865561
http://dx.doi.org/10.1039/d2ra90065c

Ejemplares similares